2 Pharmaceutical Growth Stocks to Buy Now and Hold for Decades
If you're too busy to keep monitoring your stock portfolio every other day, then investing in stocks that won't cause you a ...
Everyday Health21h
FDA Approves First Medication for Obstructive Sleep Apnea
By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...
Eli Lilly to end 2024 among best in Big Pharma; Novo among worst
Eli Lilly (LLY) emerges among the top performers in Big Pharma in 2024 with obesity drug success, while Novo Nordisk (NVO) ...
sciencenorway20h
A new medicine for almost everything – is it too good to be true?
Alzheimer's, addiction, cardiovascular diseases, kidney disorders, sleep apnoea, diabetes, obesity, and overweight.
Hosted on MSN22h
FDA Approves Zepbound in Landmark Move to Battle Obstructive Sleep Apnea
The fight against obstructive sleep apnea (OSA) has taken a monumental leap forward. For the first time, the U.S. Food and ...
israelnewsonline2h
FDA Zepbound shortage ends, impacts patients, compounding pharmacies
During FDA-declared shortages, pharmacists can legally make compounded versions of brand-name medications. But drugmakers and ...
24/7 Wall St23h
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030
Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 500.39% and ...
MedPage Today2hOpinion
CMS Moved to Expand Obesity Drug Coverage. Private Insurers Need to Step Up.
This proposed rule signals an important shift in the federal approach to obesity management, aligning with the medical ...
NDTV20h
Food News
The sculpture features Ratan Tata playing with his German Shepherd dog, Tito. Former Prime Minister Manmohan Singh preferred simple, vegetarian food. Read below to learn more about Dr. Singh's dietary ...